Article ID Journal Published Year Pages File Type
8458307 Pathology - Research and Practice 2018 6 Pages PDF
Abstract
The accumulated research data from literature has revealed that the genomic signatures of urothelial carcinoma are required to subclassify bladder cancer into genetically distinct subgroups. These findings could improve the understating of pathogenesis as well as will provide new therapeutic modules e.g. targeted therapy.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
An update on the molecular pathology of urinary bladder tumors
Authors
, ,